BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7285987)

  • 1. Immunoglobulin characterization by bacterial absorption of antibrain antibodies in multiple sclerosis.
    Ryberg B; Kronvall G
    Eur Neurol; 1981; 20(5):374-9. PubMed ID: 7285987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-fixing antibrain antibodies in multiple sclerosis. Comparison of their occurrence in cerebrospinal fluid and serum.
    Ryberg B
    Acta Neurol Scand; 1976 Jul; 54(1):1-12. PubMed ID: 936972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal and extrathecal production of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neurol Sci; 1980 Oct; 48(1):1-8. PubMed ID: 7420122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibrain antibodies in multiple sclerosis. Relation to clinical variables.
    Ryberg B
    J Neurol Sci; 1982 May; 54(2):239-61. PubMed ID: 7097299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominance of immunoglobulin G sub-class 3 among the complement-fixing antibodies to streptococcal M-associated protein.
    Mortimer GE; Widdowson JP
    Clin Exp Immunol; 1979 Aug; 37(2):247-58. PubMed ID: 498585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neurol Sci; 1982 May; 54(2):263-70. PubMed ID: 6284884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy.
    Ryberg B
    J Neurol Sci; 1978 Oct; 38(3):357-82. PubMed ID: 731263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ontogenetic mouse brain model employed in the characterization of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neuroimmunol; 1983 Feb; 4(1):9-15. PubMed ID: 6185539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid immunofluorescent procedure for the detection of specific IgG and IgM antibody in sera using Staphylococcus aureus and latex-IgG as absorbents.
    Chantler S; Devries E; Allen PR; Hurn BA
    J Immunol Methods; 1976; 13(3-4):367-80. PubMed ID: 796391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-fixing antibrain antibodies in multiple sclerosis. A preliminary report.
    Laurell AB; Link H
    Acta Neurol Scand; 1972; 48(4):461-6. PubMed ID: 5072655
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple sclerosis: search for a serologic inhibitor.
    Ryberg B
    Acta Neurol Scand; 1980 Sep; 62(3):193-6. PubMed ID: 7211171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to staphylococcal lipoteichoic acid in serum and in cerebrospinal fluid from patients with multiple sclerosis.
    Aasjord P; Nyland H
    Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):333-8. PubMed ID: 6797247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci.
    Kronvall G; Simmons A; Myhre EB; Jonsson S
    Infect Immun; 1979 Jul; 25(1):1-10. PubMed ID: 383609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
    Ryberg B; Pirskanen R
    Br Med J (Clin Res Ed); 1985 Sep; 291(6499):850-1. PubMed ID: 2996688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are anti-brain antibodies in multiple sclerosis directed to myelin basic protein? Studies employing the Shiverer mouse mutant.
    Ryberg B; Jacque C
    Acta Neurol Scand; 1986 Mar; 73(3):247-52. PubMed ID: 2424259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virus neutralizing and antibrain antibodies in multiple sclerosis and multiple encephalomyelitis].
    Zinchenko AP; ShamreÄ­ RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(4):541-8. PubMed ID: 4301248
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitation of bovine immunoglobulin G2 antibodies binding Staphylococcus aureus, using a murine monoclonal antibody.
    Mathison BA; Kelley KW; Davis WC
    Am J Vet Res; 1984 Dec; 45(12):2518-24. PubMed ID: 6395731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of blood-brain barrier permeability for complement-fixing antibodies in the pathogenesis of disseminated sclerosis].
    Leonovich AL; Ziuzenkov VV; Sizonenko TP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(3):345-9. PubMed ID: 5027045
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody to myelin basic protein in extracts of multiple sclerosis brain.
    Bernard CC; Randell VB; Horvath LB; Carnegie PR; Mackay IR
    Immunology; 1981 Jul; 43(3):447-57. PubMed ID: 6166547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different types of antibrain antibodies in multiple sclerosis. Studies employing myelin-deficient mutants of mice.
    Ryberg B; Baumann NA
    J Neurol Sci; 1983 Mar; 58(3):351-5. PubMed ID: 6842263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.